Rac GTPases in Hematological Malignancies

被引:18
作者
Durand-Onayli, Valerie [1 ]
Haslauer, Theresa [1 ]
Haerzschel, Andrea [1 ]
Hartmann, Tanja Nicole [1 ,2 ,3 ]
机构
[1] Paracelsus Med Univ, Dept Internal Med Hematol Med Oncol Hemostaseol I, Canc Cluster Salzburg, Ctr Oncol,SCRI,LIMCR, A-5020 Salzburg, Austria
[2] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany
[3] Univ Freiburg, Med Ctr, D-79106 Freiburg, Germany
基金
奥地利科学基金会;
关键词
Rac GTPases; leukemia; lymphoma; microenvironment; cancer; migration; survival; proliferation; CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITOR; NUCLEOTIDE EXCHANGE FACTOR; HEMATOPOIETIC STEM-CELLS; RHO-GTPASES; LYMPHOBLASTIC-LEUKEMIA; PROGNOSTIC RELEVANCE; THERAPEUTIC TARGET; TYROSINE KINASE; CDC42; GTPASES;
D O I
10.3390/ijms19124041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies.
引用
收藏
页数:24
相关论文
共 139 条
[91]   Spatiotemporal dynamics of RhoA activity in migrating cells [J].
Pertz, O ;
Hodgson, L ;
Klemke, RL ;
Hahn, KM .
NATURE, 2006, 440 (7087) :1069-1072
[92]   2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase [J].
Porchia, Leonardo M. ;
Guerra, Marcy ;
Wang, Yu-Chieh ;
Zhang, Yunlong ;
Espinosa, Allan V. ;
Shinohara, Motoo ;
Kulp, Samuel K. ;
Kirschner, Lawrence S. ;
Saji, Motoyasu ;
Chen, Ching-Shih ;
Ringel, Matthew D. .
MOLECULAR PHARMACOLOGY, 2007, 72 (05) :1124-1131
[93]  
Porter Andrew P, 2016, Small GTPases, V7, P123, DOI 10.1080/21541248.2016.1173767
[94]   A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer [J].
Rao, S. ;
Lyons, L. S. ;
Fahrenholtz, C. D. ;
Wu, F. ;
Farooq, A. ;
Balkan, W. ;
Burnstein, K. L. .
ONCOGENE, 2012, 31 (06) :716-727
[95]   THE SMALL GTP-BINDING PROTEIN RAC REGULATES GROWTH-FACTOR INDUCED MEMBRANE RUFFLING [J].
RIDLEY, AJ ;
PATERSON, HF ;
JOHNSTON, CL ;
DIEKMANN, D ;
HALL, A .
CELL, 1992, 70 (03) :401-410
[96]   Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense [J].
Roberts, AW ;
Kim, C ;
Zhen, L ;
Lowe, JB ;
Kapur, R ;
Petryniak, B ;
Spaetti, A ;
Pollock, JD ;
Borneo, JB ;
Bradford, GB ;
Atkinson, SJ ;
Dinauer, MC ;
Williams, DA .
IMMUNITY, 1999, 10 (02) :183-196
[97]   Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification [J].
Roberts, Patrick J. ;
Mitin, Natalia ;
Keller, Patricia J. ;
Chenette, Emily J. ;
Madigan, James P. ;
Currin, Rachel O. ;
Cox, Adrienne D. ;
Wilson, Oswald ;
Kirschmeier, Paul ;
Der, Channing J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (37) :25150-25163
[98]   Gene expression profiling of pediatric acute myelogenous leukemia [J].
Ross, ME ;
Mahfouz, R ;
Onciu, M ;
Liu, HC ;
Zhou, XD ;
Song, GC ;
Shurtleff, SA ;
Pounds, S ;
Cheng, C ;
Ma, J ;
Ribeiro, RC ;
Rubnitz, JE ;
Girtman, K ;
Williams, WK ;
Raimondi, SC ;
Liang, DC ;
Shih, LY ;
Pui, CH ;
Downing, JR .
BLOOD, 2004, 104 (12) :3679-3687
[99]  
Rudolph Joachim, 2013, Enzymes, V34 Pt. B, P157, DOI 10.1016/B978-0-12-420146-0.00007-X
[100]   DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1 [J].
Sanui, T ;
Inayoshi, M ;
Noda, M ;
Iwata, E ;
Stein, JV ;
Sasazuki, T ;
Fukui, Y .
BLOOD, 2003, 102 (08) :2948-2950